BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19147545)

  • 1. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
    Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
    Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells.
    Aaronson DS; Muller M; Neves SR; Chung WC; Jayaram G; Iyengar R; Ram PT
    Mol Cell Endocrinol; 2007 May; 270(1-2):50-6. PubMed ID: 17374439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.
    Lee SO; Lou W; Qureshi KM; Mehraein-Ghomi F; Trump DL; Gao AC
    Prostate; 2004 Sep; 60(4):303-9. PubMed ID: 15264241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
    Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.
    Malinowska K; Neuwirt H; Cavarretta IT; Bektic J; Steiner H; Dietrich H; Moser PL; Fuchs D; Hobisch A; Culig Z
    Endocr Relat Cancer; 2009 Mar; 16(1):155-69. PubMed ID: 19011039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line.
    Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC
    Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.
    Rocha J; Zouanat FZ; Zoubeidi A; Hamel L; Benidir T; Scarlata E; Brimo F; Aprikian A; Chevalier S
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):140-9. PubMed ID: 23906537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
    Landen CN; Lin YG; Armaiz Pena GN; Das PD; Arevalo JM; Kamat AA; Han LY; Jennings NB; Spannuth WA; Thaker PH; Lutgendorf SK; Savary CA; Sanguino AM; Lopez-Berestein G; Cole SW; Sood AK
    Cancer Res; 2007 Nov; 67(21):10389-96. PubMed ID: 17974982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
    Ni Z; Lou W; Leman ES; Gao AC
    Cancer Res; 2000 Mar; 60(5):1225-8. PubMed ID: 10728680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An RNA biding protein, Y14 interacts with and modulates STAT3 activation.
    Ohbayashi N; Taira N; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
    Biochem Biophys Res Commun; 2008 Aug; 372(3):475-9. PubMed ID: 18503751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
    Kooijman R; Himpe E; Potikanond S; Coppens A
    Growth Horm IGF Res; 2007 Oct; 17(5):383-91. PubMed ID: 17513150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
    Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.